GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford Cannabinoid Technologies Holdings PLC (FRA:0CB) » Definitions » Machinery, Furniture, Equipment

Oxford Cannabinoid Technologies Holdings (FRA:0CB) Machinery, Furniture, Equipment

: €0.00 Mil (As of Oct. 2023)
View and export this data going back to 2021. Start your Free Trial

Oxford Cannabinoid Technologies Holdings's Machinery, Furniture, Equipment for the quarter that ended in Oct. 2023 was €0.00 Mil.

Oxford Cannabinoid Technologies Holdings's annual Machinery, Furniture, Equipment increased from May. 2020 (€0.03 Mil) to May. 2021 (€0.03 Mil) but then declined from May. 2021 (€0.03 Mil) to Apr. 2023 (€0.00 Mil).


Oxford Cannabinoid Technologies Holdings Machinery, Furniture, Equipment Historical Data

The historical data trend for Oxford Cannabinoid Technologies Holdings's Machinery, Furniture, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxford Cannabinoid Technologies Holdings Annual Data
Trend May18 May19 May20 May21 Apr23
Machinery, Furniture, Equipment
- 0.02 0.03 0.03 -

Oxford Cannabinoid Technologies Holdings Semi-Annual Data
May19 Nov19 May20 Nov20 May21 Nov21 Oct22 Apr23 Oct23
Machinery, Furniture, Equipment Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 - - - -

Oxford Cannabinoid Technologies Holdings Machinery, Furniture, Equipment Calculation

Machinery, Furniture, Equipment represents those fixed assets specifically dealing with tools, equipment and office furniture.


Oxford Cannabinoid Technologies Holdings (FRA:0CB) Business Description

Traded in Other Exchanges
Address
267 Banbury Road, Prama House, Oxford, GBR, OX2 7HT
Oxford Cannabinoid Technologies Holdings PLC is a pharmaceutical company engaged in cannabinoid drug development. The company uses a drug development that includes proprietary cannabinoid derivatives, natural phytocannabinoids (pCBs), and in-licensed compounds. Its primary market focus is the pain market, and OCT initially aims to develop a portfolio of four drug candidates for approval as licensed pain medicines.

Oxford Cannabinoid Technologies Holdings (FRA:0CB) Headlines

No Headlines